Trial Profile
Phase II study : standard chemotherapy capecitabine in combination with bevacizumab in first-line treatment in metastatic colorectal cancer [Phase II-Studie: Standardchemotherapie Capecitabin in Kombination mit Bevacizumab in der Erstlinientherapie beim metastasierten kolorektalen Karzinom]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 16 Nov 2015 New trial record